IPG Photonics’s (NASDAQ:IPGP) Q3 sales top estimates

IPG Photonics reported Q3 revenue of $287.5M, exceeding estimates by 1.5% and growing 14.6% YoY. Adjusted EPS was $0.61, beating estimates by 24.1%. Q4 guidance was below estimates, with revenue at $280M and EPS at $0.45. Operating and free cash flow margins improved YoY.

Original reporting
Published Nov 3, 2026, 1:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 1:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
IPG Photonics’s (NASDAQ:IPGP) Q3 sales top estimates — source image
Decision brief

The 30-second read

$IPGPBullishMed
01

Why it matters

Q3 outperformance on revenue, adjusted EPS, and EBITDA contrasts with below-consensus Q4 revenue, adjusted EPS, and EBITDA guidance, creating a forward-looking valuation tension.

02

Market read

Traders can update near-term positioning based on the guidance miss despite the profitability and cash-flow improvements.

03

What to watch

Inventory days rose (180 vs 176), which can signal working-capital pressure; traders may focus on whether that reverses in subsequent quarters.

Relevance 8/10Novelty 8/10Timing: post-earnings, same-day read-through to Q4 expectations

Background

The piece summarizes IPG Photonics’ Q3 performance versus analyst consensus and provides Q4 2026 guidance at the midpoint.

Company-level read

Ticker impact

$IPGPBullishHigh confidence
Context

IPG Photonics reported Q3 revenue and adjusted EPS beats, but guided Q4 revenue, EPS, and EBITDA below consensus.

Expected impact

Likely mixed-to-negative reaction as the market weighs strong Q3 profitability versus weaker Q4 guidance.

Evidence & confidence

The article provides both upside surprises (revenue, adjusted EPS, EBITDA) and explicit downside guidance (revenue, adjusted EPS, EBITDA) for Q4, which typically drives the dominant forward-looking repricing.

Market effects

Optics/photonics peers may see read-across on demand durability and margin resilience, but guidance direction is the key takeaway.

Primarily US-listed sentiment; limited direct regional spillover beyond semiconductor/industrial optics supply chains.

Global optics demand expectations could be nudged, though the article is company-specific rather than a sector-wide datapoint.

Counterpoint

The Q3 margin and free-cash-flow improvement could indicate operating leverage, and the Q4 guidance miss may reflect timing rather than demand deterioration.

Key entities

  • IPG Photonics

    NASDAQ-listed photonics company reporting Q3 results and issuing Q4 2026 guidance.

Related articles

$IPGPMed

Why IPG Photonics (IPGP) shares are falling today

IPG Photonics (IPGP) shares fell 9.8% after Democratic senators called for slowing AI data center development, impacting chipmakers. Micron paused a $4.5B plant in Taiwan due to labor disputes. IPGP is down 15.9% YTD, trading 59.2% below its 52-week high. Rising Treasury yields also weigh on semiconductor stocks.

$IPGPMed

IPG Photonics Corp (IPGP) (Q3 2026) Earnings Call Highlights: Fourth Straight Quarter

IPG Photonics (IPGP) expects Q4 revenue of $265-$295M, with adjusted gross margin declining to 37-40% due to lower tariff refunds. European sales fell 1% YoY, while defense revenue is lumpy. CEO Dr. Mark Gitin sees long-term growth in battery, semiconductor, and medical sectors. CFO Timothy Mammen notes cost pressures but expects gross margin improvements in 2027. Medical and semiconductor are key growth drivers.

$IPGPLow

IPG Photonics (IPGP) Beat Q3 Estimates, Is It Still Below Fair Value?

IPG Photonics (IPGP) reported Q3 2026 sales of $287.5M and net income of $20.27M, beating estimates. Despite this, shares fell 11.46% in 30 days and 11.40% over 1 year. The stock closed at $74.42, with some analysts valuing it 40% below fair value at $124.14, citing growth opportunities. However, its P/E ratio of 114.9x raises valuation concerns compared to industry peers.

MedAI 8/10

IPG Photonics Corporation Q3 2026 Earnings Call Summary

IPG Photonics reported Q3 2026 revenue growth of 15%, driven by industrial and advanced solutions. Advanced Solutions revenue surged 33% YoY, led by semiconductor and defense applications. The company expects medical business growth to double in 2-3 years post-Lumibird Medical acquisition. Q4 guidance accounts for moderation in China's battery capacity additions. The company maintains a strong balance sheet with $926M in cash and no debt.

$IPGPMedAI 8/10

IPG Photonics (IPGP) Q3 2026 Earnings Call Transcript

IPG Photonics (IPGP) reported Q3 2026 earnings, with revenue up 15% YoY to $288M. Industrial Solutions revenue grew 12% YoY, driven by welding and additive manufacturing. Advanced Solutions revenue increased 33% YoY, with strong growth in semiconductor and defense applications. The company announced the acquisition of Lumibird Medical, expected to close in Q4, expanding its medical laser platform. IPGP plans to host an Investor Day on March 2, 2027.